Medicine and Dentistry
Congestive Heart Failure
100%
Biological Marker
66%
Hemodynamic
36%
Quality of Life
33%
Clinical Endpoint
33%
Prognostication
33%
Combination Therapy
33%
Heart Failure with Reduced Ejection Fraction
33%
Sex Difference
33%
Lung Artery Pressure
33%
Diseases
12%
Cardiovascular System
9%
Optimal Drug Dose
6%
Low Drug Dose
6%
Pathophysiology
6%
Drug Distribution
6%
Drug Absorption
6%
Angiotensin Receptor Antagonist
6%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Biological Marker
66%
Heart Failure with Reduced Ejection Fraction
33%
Combination Therapy
33%
Prostate Specific Membrane Antigen
33%
Retrospective Study
33%
Prostate Cancer
33%
Radioligand
33%
Diseases
14%
Lutetium 177
10%
Actinium 225
8%
Angiotensin Receptor Antagonist
6%
Drug Distribution
6%
Drug Absorption
6%
Pathophysiology
6%
Castration Resistant Prostate Cancer
5%
Nursing and Health Professions
Quality of Life
33%
Heart Failure with Reduced Ejection Fraction
33%
Gender Difference
33%
Combination Therapy
33%
Congestive Heart Failure
33%
Pathophysiology
6%
Practice Guideline
6%
Optimal Drug Dose
6%
Angiotensin Receptor Antagonist
6%
Low Drug Dose
6%
